A low, daily dose of aspirin has been praised for its cardiovascular benefits, but new research shows that the therapy may also ward off pancreatic cancer, one of the deadliest forms of the disease. The study, conducted by researchers at the Yale School of Public Health, claims daily low-dose aspirin therapy can lower pancreatic cancer risk by up to 48 percent. Low-dose aspirn therapy has already been credited for reducing risk of ovarian, colorectal, stomach, esophageal, prostate, breast, lung, and skin cancers. Researchers studied information on aspirin use and medical histories for 362 people with pancreatic cancer and 690 people ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.